Literature DB >> 3040303

Decreased Na+K+ATPase activity in the aortic endothelium and smooth muscle of the spontaneously hypertensive rats.

S Manjeet, M K Sim.   

Abstract

The activity of Na+K+ ATPase in the endothelium and smooth muscle of the aortae of normotensive and hypertensive rats was investigated. The enzyme activity in the endothelium and smooth muscle of the spontaneously hypertensive rats (SHR) was 2.15 +/- 0.48 and 12.98 +/- 0.99 respectively. These values were significantly lower (P less than 0.05) than the enzyme activity in the corresponding tissues (10.10 +/- 1.78 for endothelium, 20.77 +/- 2.54 for smooth muscle) of the normotensive Wistar Kyoto (WKY) rats. However, with the low blood pressure spontaneously hypertensive rats (LBP-SHR) i.e. in those animals whose blood pressures were below 150 mm Hg, the enzyme activity in both tissues was not significantly different from those of the WKY. Since Na+ K+ ATPase is coupled to the sodium-potassium pump whose activity affects the functions of other pumps, the results indicate that the development of high blood pressure in the SHR may be related to an alteration in the transport of cations across the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040303     DOI: 10.3109/10641968709161450

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  3 in total

1.  Ultracytochemical localisation of Na+, K(+)-ATPase in cerebral endothelium in acute hypertension.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  The effect of high calcium intake on Ca2+ ATPase and the tissue Na:K ratio in spontaneously hypertensive rats.

Authors:  H Wuorela; P Arvola; I Pörsti; E Siltaloppi; P Säynävälammi; H Vapaatalo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

3.  Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats.

Authors:  P Arvola; I Pörsti; P Vuorinen; A Pekki; H Vapaatalo
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.